Profile Summary

Medical Qualification: MBBS, MRCP (UK), Diploma Diabetology, FACP (USA)

Designation: Consultant, Diabetology & Metabloic Physician

Years of experience: 21 years

Area of expertise:

• Diabetes
• Thyroid
• Obesity 
• PCOD
• Vitamin D & Bone Metabolism 

Introduction:

Dr. Vyankatesh Shivane is MRCP (UK), Consultant Diabetologist & Metabolic Physician. He has completed his graduation and post-graduation from prestigious institute, Seth G.S.Medical College & K.E.M. Hospital Mumbai. He has been member of Royal College of Physicians, United Kingdom. He is member of Endocrine Society USA.

He has 21 years of experience in practice. He has more than 40 peer reviewed international publications on his credit. He has vast experience of clinical research and has extensively worked in the field of research in diabetes, thyroid & endocrine diseases. He has more than 75 clinical trials on his credit as an investigator & co-investigator.

He has been faculty for ICMR and various organizations and has delivered many lectures nationally and internationally. He has been actively involved in patient education in print and visual media like Doordarshan, BBC, Loksatta, Lokmat etc.

His special emphasis is on life style modification, preventive diabetology & management of obesity.

He is sub editor of journal of post graduate medicine and section editor of journal of diabetes, obesity and metabolism.

He has been invited as an expertise to CDSCO, DCGI office, New Delhi for expert opinion on fixed dose combination therapy. He was involved in starting speciality OPDs like young Diabetes OPD, Gesttional Diabetic Mother opd and other inter-disciplinary clinics in Endocrinology in KEM Hospital. Dr Shivane was also involved as a faculty for IDC-WHO collaboration for management and prevention of diabetes in Maharashtra.

Awards & Publications:

Awards & Publications:

• More than 40 peer reviewed international publications
• Authored a chapter in CDiC textbook of Paediatric Diabetes
• Effect of Airborne Low Intensity Multi frequency ultrasound (ALIMFUS) on glycemic control, lipid profile and markers of inflammation in patients with uncontrolled type 2 diabetes: A multicentre proof of concept, randomized double blind Placebo controlled study. Shivane V, Pathak H, Tamoli S, Kohli KR, Ghungralekar R, Deshmukh P, Hartalkar A, Mahadik S, Indalkar P, Mehta B. Diabetes Metab Syndr. 2022 May; 16(5): 102483. doi: 10.1016/j.dsx.2022.102483. Epub 2022 Apr 23. PMID: 35483209 Clinical Trial
• Prevalence of primary aldosteronism in type 2 diabetes mellitus and hypertension: A prospective study from Western India. Memon SS, Lila A, Barnabas R, Goroshi M, Sarathi V, Shivane V, Patil V, Shah N, Bandgar T.Clin Endocrinol (Oxf). 2021 Sep 27. doi: 10.1111/cen.14598. Online ahead of print
• Type 2 diabetic Asian Indians and COVID-19: Lessons learnt so far from the ongoing pandemic.Shivane VK, Lila AR, Bandgar TR.J Postgrad Med. 2020 Oct-Dec;66(4):179-181. doi: 10.4103/jpgm.JPGM_602_20
• Genetic spectrum and predictors of mutations in four known genes in Asian Indian patients with growth hormone deficiency and orthotopic posterior pituitary: an emphasis on regional genetic diversity. Kale S, Gada JV, Jadhav S, Lila AR, Sarathi V, Budyal S, Patt H, Goroshi MR, Thadani PM, Arya S, Kamble AA, Patil VA, Acharya S, Sankhe S, Shivane V, Raghavan V, Bandgar TR, Shah NS.Pituitary. 2020 Dec;23(6):701-715. doi: 10.1007/s11102-020-01078-4
• Corrigendum to 'A novel gross indel in the growth hormone releasing hormone receptor gene of Indian IGHD patients.' [Growth Hormone & IGF Research 24 (2014) 227-232]. Kale S, Budyal S, Kasaliwal R, Shivane V, Raghavan V, Lila A, Bandgar T, Growth Horm IGF Res. 2019 Apr 29. pii: S1096-6374(19)30021-8. doi: 10.1016/j.ghir.2019.04.001
• Transoral endoscopic thyroidectomy using vestibular approach: A single center experience. Rege SA, Janesh M, Surpam S, Shivane V, Arora A, Singh A. Rege SA, Janesh M, Surpam S, Shivane V, Arora A, Singh A.J Postgrad Med. 2019 Apr-Jun;65(2):81-86. doi: 10.4103/jpgm.JPGM_117_18
• A 52-week extension study of switching from gemigliptin vs sitagliptin to gemigliptin only as add-on therapy for patients with type 2 diabetes who are inadequately controlled with metformin alone. Jung CH, Rhee EJ, Lee WY, Min KW, Shivane VK, Sosale AR, Jang HC, Chung CH, Nam-Goong IS; Gemigliptin Study 006 Group
• Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial. Ma RC, Del Prato S, Gallwitz B, Shivane VK, Lewis-D'Agostino D, Bailes Z, Patel S, Lee J, von Eynatten M, Di Domenico M, Ross SA
• Liraglutide and Renal Outcomes in Type 2 Diabetes. Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators
• Genotype-phenotype correlation in paediatric pheochromocytoma and paraganglioma: a single centre experience from India. Khadilkar K, Sarathi V, Kasaliwal R, Pandit R, Goroshi M, Shivane V, Lila A, Bandgar T, Shah NS
• Hashimoto's thyroiditis: relative recurrence risk ratio and implications for screening of first-degree relatives. Bothra N, Shah N, Goroshi M, Jadhav S, Padalkar S, Thakkar H, Toteja GS, Shivane V, Lila A, Bandgar T
• Predictors of malignancy in patients with pheochromocytomas/paragangliomas: Asian Indian experience. Khadilkar K, Sarathi V, Kasaliwal R, Pandit R, Goroshi M, Malhotra G, Dalvi A, Bakshi G, Bhansali A, Rajput R, Shivane V, Lila A, Bandgar T, Shah NS
• Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma. Pandit R, Khadilkar K, Sarathi V, Kasaliwal R, Goroshi M, Khare S, Nair S, Raghavan V, Dalvi A, Hira P, Fernandes G, Sathe P, Rojekar A, Malhotra G, Bakshi G, Prakash G, Bhansali A, Walia R, Kamalanathan S, Sahoo J, Desai A, Bhagwat N, Mappa P, Rajput R, Chandrashekhar SR, Shivane V, Menon P, Lila A, Bandgar T, Shah N
• Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma. Pandit R, Khadilkar K, Sarathi V, Kasaliwal R, Goroshi M, Khare S, Nair S, Raghavan V, Dalvi A, Hira P, Fernandes G, Sathe P, Rojekar A, Malhotra G, Bakshi G, Prakash G, Bhansali A, Walia R, Kamalanathan S, Sahoo J, Desai A, Bhagwat N, Mappa P, Rajput R, Chandrashekhar SR, Shivane V, Menon P, Lila A, Bandgar T, Shah N
• Genetically Confirmed Neonatal Diabetes: A Single Centre Experience. Dalvi NN, Shaikh ST, Shivane VK, Lila AR, Bandgar TR, Shah NS.Indian J Pediatr. 2017 Jan;84(1):86-88. doi: 10.1007/s12098-016-2203-2. Epub 2016 Aug 6. No abstract available
• Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators.N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13
• Spectrum of phenotype and genotype of congenital isolated hypogonadotropic hypogonadism in Asian Indians. Nair S, Jadhav S, Lila A, Jagtap V, Bukan A, Pandit R, Ekbote A, Dharmalingam M, Kumar P, Kalra P, Gandhi P, Walia R, Sankhe S, Raghavan V, Shivane V, Menon P, Bandgar T, Shah N
• Is it worthwhile to screen patients with type 2 diabetes mellitus for subclinical Cushing's syndrome? Budyal S, Jadhav SS, Kasaliwal R, Patt H, Khare S, Shivane V, Lila AR, Bandgar T, Shah NS.Endocr Connect. 2015 Dec;4(4):242-8. doi: 10.1530/EC-15-0078. Epub 2015 Sep 29
• Bone mineral density and factors influencing it in Asian Indian population with type 2 diabetes mellitus. Kamalanathan S, Nambiar V, Shivane V, Bandgar T, Menon P, Shah N
• The performance and reproducibility of late-night salivary cortisol estimation by enzyme immunoassay for screening Cushing disease. Bukan AP, Dere HB, Jadhav SS, asaliwal RR, Budyal SR, Shivane VK, Lila AR, Bandgar TR, Shah NS.Endocr Pract. 2015 Feb;21(2):158-64. doi: 10.4158/EP14186.OR
• A novel gross indel in the growth hormone releasing hormone receptor gene of Indian IGHD patients. Kale S, Budyal S, Kasaliwal R, Shivane V, Raghavan V, Lila A, Bandgar T, Shah N. Growth Horm IGF Res. 2014 Dec;24(6):227-32. doi: 10.1016/j.ghir.2014.07.003. Epub 2014 Aug 7. Erratum in: Growth Horm IGF Res. 2019 Apr 29
• Pioglitazone: Hype and hope. Jadhav SS, Shivane VK, Lila AR, Bandgar TR, Shah NS. J Postgrad Med. 2014 Jul-Sep;60(3):293-6. doi: 10.4103/0022-3859.138765. No abstract available
• Current concepts in blood glucose monitoring. Khadilkar KS, Bandgar T, Shivane V, Lila A, Shah N. Indian J Endocrinol Metab. 2013 Dec; 17(Suppl 3):S643-9. doi: 10.4103/2230-8210.123556. Review
• An objective olfactory evaluation and its correlation with magnetic resonance imaging findings in Asian Indian patients with idiopathic hypogonadotropic hypogonadism.Jagtap VS, Sarathi V, Lila AR, Nair S, Bukan A, Sankhe SS, Shivane V, Bandgar T, Menon P, Shah NS.Endocr Pract. 2013 Jul-Aug;19(4):669-74. doi: 10.4158/EP13008.OR
• Efficacy and safety of the dipeptidyl peptidase-4 inhibitor gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with Metformin alone. Rhee EJ, Lee WY, Min KW, Shivane VK, Sosale AR, Jang HC, Chung CH, Nam-Goong IS, Kim JA, Kim SW; Gemigliptin Study 006 Group.Diabetes Obes Metab. 2013 Jun;15(6):523-30. doi: 10.1111/dom.12060. Epub 2013 Jan 30
• A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15-0444) in patients with type 2 diabetes. Yang SJ, Min KW, Gupta SK, Park JY, Shivane VK, Pitale SU, Agarwal PK, Sosale A, Gandhi P, Dharmalingam M, Mohan V, Mahesh U, Kim DM, Kim YS, Kim JA, Kim PK, Baik SH.Diabetes Obes Metab. 2013 May; 15(5):410-6. doi: 10.1111/dom.12042. Epub 2012 Dec 17
• Chronic liver disease and skeletal health (hepatic osteodystrophy). Bandgar T, Shivane V, Lila A, Shah N.J Postgrad Med. 2012 Apr-Jun; 58(2):103-6. doi: 10.4103/0022-3859.97170. No abstract available
• Peak bone mineral density and its determinants in an Asian Indian population. Shivane VK, Sarathi V, Lila AR, Bandgar T, Joshi SR, Menon PS, Shah NS. J Clin Densitom. 2012 Apr-Jun;15(2):152-8. doi: 10.1016/j.jocd.2011.12.007. Epub 2012 Mar 7
• Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study. Russell-Jones D, Cuddihy RM, Hanefeld M, Kumar A, González JG, Chan M, Wolka AM, Boardman MK; DURATION-4 Study Group.Diabetes Care. 2012 Feb;35(2):252-8. doi: 10.2337/dc11-1107. Epub 2011 Dec 30
• Managing non-ketotic childhood hyperglycemia. Shivane V, Lila A, Bandgar T, Shah N. J Postgrad Med. 2011 Oct-Dec;57(4):270-1. doi: 10.4103/0022-3859.90073. No abstract available
• High prevalence of hypovitaminosis D in young healthy adults from the western part of India. Shivane VK, Sarathi V, Bandgar T, Menon P, Shah NS. Postgrad Med J. 2011 Aug; 87(1030):514-8. doi: 10.1136/pgmj.2010.113092. Epub 2011 Apr 20
• Study of bone mineral density in resident doctors working at a teaching hospital. Multani SK, Sarathi V, Shivane V, Bandgar TR, Menon PS, Shah NS. J Postgrad Med. 2010 Apr-Jun;56(2):65-70. doi: 10.4103/0022-3859.65272
• The value of an acute octreotide suppression test in predicting response to long-term somatostatin analogue therapy in patients with acromegaly.Bandgar TR, Sarathi V, Shivane V, Bansode N, Menon PS, Shah NS. J Postgrad Med. 2010 Jan-Mar;56(1):7-11. doi: 10.4103/0022-3859.62421
• Pilot study to evaluate the effect of short-term improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes mellitus. Parekh D, Sarathi V, Shivane VK, Bandgar TR, Menon PS, Shah NS. Endocr Pract. 2010 Jul-Aug;16(4):600-8. doi: 10.4158/EP09300.OR
• Bone mineral density and disorders of mineral metabolism in chronic liver disease. George J, Ganesh HK, Acharya S, Bandgar TR, Shivane V, Karvat A, Bhatia SJ, Shah S, Menon PS, Shah N.World J Gastroenterol. 2009 Jul 28;15(28):3516-22
• Prevalence of hypogonadism in patients with type 2 diabetes mellitus in an Asian Indian study group. Ganesh HK, Vijaya Sarathi HA, George J, Shivane VK, Bandgar T, Menon PS, Shah NS. Endocr Pract. 2009 Sep-Oct;15(6):513-20. doi: 10.4158/EP09035.ORR
• Prevalence of carbohydrate intolerance of varying degrees in pregnant females in estern India (Maharashtra)--a hospital-based study. Swami SR, Mehetre R, Shivane V, Bandgar TR, Menon PS, Shah NS.J Indian Med Assoc. 2008 Nov;106(11):712-4, 7

Memberships:

Memberships:

• Research Society for Study of Diabetes in India (RSSDI)
• Diabetic Foot Society of India (DFSI)
• Endocrine Society, USA
• Member of Royal College of Physicians
• Fellowship of American College of Physicians (2015)